{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:39:51Z","timestamp":1790707191653,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>The role of autoimmunity in the pathogenesis of gastric cancer remains controversial. We studied antiparietal cell antibody (anti-PCA) and anti-intrinsic factor antibody (anti-IFA) levels and their associations with pepsinogen I\/pepsinogen II levels in patients with gastric adenocarcinoma compared to a control group with mild or no atrophy of the stomach mucosa. Plasma levels of anti-PCA and anti-IFA were measured by ELISA (Inova Diagnostics Inc, San Diego, California, USA). The cutoff value for anti-PCA and anti-IFA positivity was \u226525\u2005units. Altogether 214 patients (126 men, 88 women, median age 64.46, range: 35\u201386) with confirmed gastric adenocarcinoma and 214 control cases paired for age and sex were included in the study. Positive anti-PCA was present in 22 (10.3%) gastric cancer patients and controls (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\u2265\u20050.999); positive anti-IFA in 6 (2.8%) and 4 (1.9.%), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.232, respectively.<\/jats:p>\n          <jats:p>We did not find significant differences in anti-PCA and anti-IFA positivity between gastric cancer patients and the control group; further investigation is required to better understand the potential involvement of autoimmune gastritis in the development of gastric cancer.<\/jats:p>","DOI":"10.1097\/cej.0000000000000826","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:00:08Z","timestamp":1704276008000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Autoimmune gastritis serological biomarkers in gastric cancer patients"],"prefix":"10.1097","volume":"33","author":[{"given":"Petra","family":"Kri\u0137e","sequence":"first","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"},{"name":"Pauls Stradins Clinical University Hospital, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meret Sophia","family":"Appel","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[{"name":"Headquarters & Technology Center Autoimmunity, Werfen, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inese","family":"Po\u013caka","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Kojalo","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Rudz\u012bte","sequence":"additional","affiliation":[{"name":"Riga East University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivars","family":"Tolmanis","sequence":"additional","affiliation":[{"name":"Digestive Diseases Centre GASTRO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnis","family":"Kir\u0161ners","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Bogdanova","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"},{"name":"Riga East University Hospital"},{"name":"Academic Histology Laboratory, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Aleksandravica","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[{"name":"Headquarters & Technology Center Autoimmunity, Werfen, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0101rcis","family":"Leja","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia"},{"name":"Riga East University Hospital"},{"name":"Digestive Diseases Centre GASTRO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajcp\/aqy061","article-title":"Estimate of the prevalence of anti-gastric parietal cell autoantibodies in healthy individuals is method dependent.","volume":"150","author":"Bagnasco","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"R3-20250527","article-title":"Protocol for the examination of specimens from patients with carcinoma of the stomach.","author":"Burgart","year":"2022","journal-title":"Coll Am Pathol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imlet.2012.06.004","article-title":"Factors associated with parietal cell autoantibodies in the general population.","volume":"147","author":"Cabrera de Leon","year":"2012","journal-title":"Immunol Lett"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/jcm12031062","article-title":"Incidence of gastric neoplasms arising from autoimmune metaplastic atrophic gastritis: a systematic review and case reports.","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.3748\/wjg.v21.i42.12179","article-title":"Autoimmune gastritis: pathologist\u2019s viewpoint.","volume":"21","author":"Coati","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/gast.2001.21187","article-title":"H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis.","volume":"120","author":"D\u2019Elios","year":"2001","journal-title":"Gastroenterology"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"952674","DOI":"10.3389\/fimmu.2022.952674","article-title":"Gastric Th17 cells specific for H(+)\/K(+)-ATPase and serum IL-17 signature in gastric autoimmunity.","volume":"13","author":"Della Bella","year":"2022","journal-title":"Front Immunol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00018-012-0970-0","article-title":"Immune aging and autoimmunity.","volume":"69","author":"Goronzy","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"e0142080","DOI":"10.1371\/journal.pone.0142080","article-title":"Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis.","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classificatioN.","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis.","volume":"6","author":"Lenti","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R13-20250527","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of helicobacter pylori infection: the maastricht VI\/Florence consensus report.","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2018.08.011","article-title":"The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective.","volume":"18","author":"Massironi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R15-20250527","first-page":"e729","article-title":"Review: gastric malignancies \u2013 bugs, pathways and molecular programs.","volume":"4","author":"Mendes-Rocha","year":"2022","journal-title":"Microb Health Dis"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system.","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12328-019-01074-7","article-title":"Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach.","volume":"13","author":"Nehme","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","article-title":"Autoimmune atrophic gastritis--pathogenesis, pathology and management.","volume":"10","author":"Neumann","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"e12975","DOI":"10.1111\/hel.12975","article-title":"Considerations in comparing intestinal- and diffuse-type gastric adenocarcinomas.","volume":"28","author":"Piazuelo","year":"2023","journal-title":"Helicobacter"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.28999","article-title":"Global burden of gastric cancer attributable to helicobacter pylori.","volume":"136","author":"Plummer","year":"2015","journal-title":"Int J Cancer"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system.","volume":"56","author":"Rugge","year":"2007","journal-title":"Gut"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1365-2036.2012.05101.x","article-title":"Autoimmune gastritis: histology phenotype and OLGA staging.","volume":"35","author":"Rugge","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/gutjnl-2022-327827","article-title":"Autoimmune gastritis: long-term natural history in na\u00efve Helicobacter pylori-negative patients.","volume":"72","author":"Rugge","year":"2023","journal-title":"Gut"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"17562848211038771","DOI":"10.1177\/17562848211038771","article-title":"Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management.","volume":"14","author":"Rustgi","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"issue":"Suppl 13","key":"R25-20250527","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02990098","article-title":"Gastric cancer: pathogenesis, risks, and prevention.","volume":"37","author":"Sipponen","year":"2002","journal-title":"J Gastroenterol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11938-018-0203-1","article-title":"Gastric cancer: an evolving disease.","volume":"16","author":"Song","year":"2018","journal-title":"Curr Treat Options Gastroenterol"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamaoncol.2021.5395","article-title":"Association of antiparietal cell and anti-intrinsic factor antibodies with risk of gastric cancer.","volume":"8","author":"Song","year":"2022","journal-title":"JAMA Oncol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1440-1746.2005.03983.x","article-title":"Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.","volume":"21","author":"Taguchi","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.autrev.2014.01.048","article-title":"Diagnosis and classification of autoimmune gastritis.","volume":"13","author":"Toh","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.autrev.2010.08.006","article-title":"Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases.","volume":"10","author":"Tozzoli","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2050640619891580","article-title":"Gastric cancer in autoimmune gastritis: a case-control study from the German centers of the staR project on gastric cancer research.","volume":"8","author":"Weise","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-12-1343","article-title":"Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany.","volume":"22","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:04:56Z","timestamp":1748361896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000826","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,30]]}}}